Indian Corona Virus Vaccine "COVAXIN" gets approved in India for Phase I and Phase II

India's regulator, Central Drugs Standard Control Organization has approved Bharat Biotech India to conduct human clinical trials for its 'COVAXIN'.  Phase I and Phase II trials start in July 2020

Bharath Biotech in collaboration with the Indian Council of Medical Research's(ICMR) National Institute of Virology(NIV)

Others in the queue:

Zydus Cadilla

Serum Institute of India

Panacea Biotec

More here: http://bitly.ws/8V7B